Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mott

Showing results (161-170 of 254) with videos related to

Pageof 26
Sort By:
Journal of Lipid Research|June 3, 2011
A role for miR-296 in the regulation of lipoapoptosis by targeting PUMASophie C Cazanave, Justin L Mott, Nafisa A Elmi, et al.
Frontiers in Psychology|October 17, 2022
Patient reported quality of life in young adults with sarcoma receiving care at a sarcoma centerJonathan R Day, Benjamin Miller, Bradley T Loeffler, et al.
Clinical Genitourinary Cancer|June 25, 2016
Gleason Score ≤ 6 Prostate Cancer at Radical Prostatectomy: Does a High-Risk Setting Truly Exist? A Recursive Partitioning AnalysisJohn M Watkins, Darrion L Mitchell, J Kyle Russo, et al.
The Journal of Urology|July 13, 2022
Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder CancerIan M McElree, Vignesh T Packiam, Ryan L Steinberg, et al.
Cancer Letters|December 18, 2016
Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cellsPenn Muluhngwi, Abirami Krishna, Stephany L Vittitow, et al.
Plos One|April 22, 2021
Saturated free fatty acids induce placental trophoblast lipoapoptosisSathish Kumar Natarajan, Taylor Bruett, Philma Glora Muthuraj, et al.
Urology|February 13, 2024
Longitudinal Outcomes of Malignant Ureteral Obstruction Secondary to Ovarian Cancer: Predictors of Resolution and the Role of Surgical ManagementKathryn N Faidley, Hannah E Botkin, Bradley T Loeffler, et al.
Urologic Oncology|May 25, 2025
Bladder-sparing management for high grade noninvasive urothelial carcinoma of the prostateAlexander C Martin, Ian M McElree, Sarah L Mott, et al.
Surgery|December 6, 2021
The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancerCatherine G Tran, Paolo Goffredo, Sarah L Mott, et al.
Oncotargets and Therapy|January 27, 2017
VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myelomaKalyan Nadiminti, Kamal Kant Singh Abbi, Sarah L Mott, et al.
Pageof 26

Showing results (161-170 of 254) with videos related to

Sort By:
Pageof 26
Journal of Lipid Research|June 3, 2011
A role for miR-296 in the regulation of lipoapoptosis by targeting PUMASophie C Cazanave, Justin L Mott, Nafisa A Elmi, et al.
Frontiers in Psychology|October 17, 2022
Patient reported quality of life in young adults with sarcoma receiving care at a sarcoma centerJonathan R Day, Benjamin Miller, Bradley T Loeffler, et al.
Clinical Genitourinary Cancer|June 25, 2016
Gleason Score ≤ 6 Prostate Cancer at Radical Prostatectomy: Does a High-Risk Setting Truly Exist? A Recursive Partitioning AnalysisJohn M Watkins, Darrion L Mitchell, J Kyle Russo, et al.
The Journal of Urology|July 13, 2022
Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder CancerIan M McElree, Vignesh T Packiam, Ryan L Steinberg, et al.
Cancer Letters|December 18, 2016
Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cellsPenn Muluhngwi, Abirami Krishna, Stephany L Vittitow, et al.
Plos One|April 22, 2021
Saturated free fatty acids induce placental trophoblast lipoapoptosisSathish Kumar Natarajan, Taylor Bruett, Philma Glora Muthuraj, et al.
Urology|February 13, 2024
Longitudinal Outcomes of Malignant Ureteral Obstruction Secondary to Ovarian Cancer: Predictors of Resolution and the Role of Surgical ManagementKathryn N Faidley, Hannah E Botkin, Bradley T Loeffler, et al.
Urologic Oncology|May 25, 2025
Bladder-sparing management for high grade noninvasive urothelial carcinoma of the prostateAlexander C Martin, Ian M McElree, Sarah L Mott, et al.
Surgery|December 6, 2021
The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancerCatherine G Tran, Paolo Goffredo, Sarah L Mott, et al.
Oncotargets and Therapy|January 27, 2017
VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myelomaKalyan Nadiminti, Kamal Kant Singh Abbi, Sarah L Mott, et al.
Pageof 26